ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Taurx Therapeutics Europe Ltd

Taurx Therapeutics Europe Ltd is an active company incorporated on 31 March 2016 with the registered office located in Aberdeen, City of Aberdeen. Taurx Therapeutics Europe Ltd was registered 9 years ago.
Status
Active
Active since 7 years ago
Company No
SC531194
Private limited company
Scottish Company
Age
9 years
Incorporated 31 March 2016
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 30 March 2025 (5 months ago)
Next confirmation dated 30 March 2026
Due by 13 April 2026 (7 months remaining)
Last change occurred 8 years ago
Accounts
Submitted
For period 1 Jul30 Jun 2024 (1 year)
Accounts type is Micro Entity
Next accounts for period 30 June 2025
Due by 31 March 2026 (6 months remaining)
Contact
Address
395 King Street
Aberdeen
AB24 5RP
Scotland
Same address for the past 7 years
Telephone
01224 646311
Email
Unreported
Website
People
Officers
2
Shareholders
1
Controllers (PSC)
1
Director • Chief Operating Officer & Chief Business Officer • British • Lives in Scotland • Born in Mar 1970
Director • Physician • British • Lives in UK • Born in Jun 1949
Taurx Therapeutics Management Ltd
PSC
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Taurx Therapeutics Management Ltd
Professor Claude Wischik and Dr Glenn Andrew Corr are mutual people.
Active
Taurx Dynamic Solutions Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Taurx Advanced Therapeutics Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Taurx Biological Solutions Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Tau Corp Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Taurx Enterprise Synergies Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Taurx Hibernia Limited
Dr Glenn Andrew Corr is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2017–2024)
Period Ended
30 Jun 2024
For period 30 Jun30 Jun 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£200
Same as previous period
Total Liabilities
-£14.63K
Increased by £1.85K (+14%)
Net Assets
-£14.43K
Decreased by £1.85K (+15%)
Debt Ratio (%)
7314%
Increased by 924.5% (+14%)
Latest Activity
Dr Glenn Andrew Corr Details Changed
4 Months Ago on 25 Apr 2025
Confirmation Submitted
5 Months Ago on 8 Apr 2025
Micro Accounts Submitted
5 Months Ago on 21 Mar 2025
Dr Glenn Andrew Corr Appointed
1 Year 1 Month Ago on 23 Jul 2024
Confirmation Submitted
1 Year 4 Months Ago on 12 Apr 2024
Micro Accounts Submitted
1 Year 5 Months Ago on 12 Mar 2024
Confirmation Submitted
2 Years 4 Months Ago on 11 Apr 2023
Micro Accounts Submitted
2 Years 6 Months Ago on 9 Mar 2023
Micro Accounts Submitted
3 Years Ago on 22 Apr 2022
Confirmation Submitted
3 Years Ago on 21 Apr 2022
Get Credit Report
Discover Taurx Therapeutics Europe Ltd's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Director's details changed for Dr Glenn Andrew Corr on 25 April 2025
Submitted on 10 Jul 2025
Confirmation statement made on 30 March 2025 with no updates
Submitted on 8 Apr 2025
Micro company accounts made up to 30 June 2024
Submitted on 21 Mar 2025
Appointment of Dr Glenn Andrew Corr as a director on 23 July 2024
Submitted on 23 Jul 2024
Confirmation statement made on 30 March 2024 with no updates
Submitted on 12 Apr 2024
Micro company accounts made up to 30 June 2023
Submitted on 12 Mar 2024
Confirmation statement made on 30 March 2023 with no updates
Submitted on 11 Apr 2023
Micro company accounts made up to 30 June 2022
Submitted on 9 Mar 2023
Micro company accounts made up to 30 June 2021
Submitted on 22 Apr 2022
Confirmation statement made on 30 March 2022 with no updates
Submitted on 21 Apr 2022
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year